The Arthritis Foundation endorses the Ezy Dose AM/PM Push Button Pill Organizer

Ease of Use products have been specifically designed and certified to make tasks easier for people who live in pain.

BURNSVILLE, Minn. (PRWEB)
November 11, 2021

The only pill organizers endorsed by the Arthritis Foundation® come from Apothecary Products, a global leader in consumer wellness products.

The Ezy Dose® push button line, including the Push Button AM/PM Weekly Pill Organizer, has been certified by the Arthritis Foundation as an Ease of Use product. The Arthritis Foundation states that, “Ease of Use products have been specifically designed and certified to make tasks easier for people who live in pain.” Products such as the Ezy Dose push button pill organizers remove some of the burden of accomplishing everyday tasks for those suffering any level of arthritis pain.

“Our purpose is to help consumers improve their health and wellness, and we are committed to designing products that do that,” said Marketing Director Dan Flygare. “A push button on a pill organizer is a simple but highly effective way to help make an everyday task a little easier.”

Ezy Dose Push Button Pill Organizers were designed by pharmacists and feature large, strain-free push buttons that pop open each compartment, removing the burden on fingers or hands caused by pinching or pulling. The push button grants easy access to the pill organizer, allowing even those with arthritis pain or dexterity concerns to organize their daily medications to prevent confusion and aid in sticking to a correct and consistent medication plan.

In addition to the Push Button AM/PM Weekly Pill Organizer, other Ezy Dose pill planners that fall under the Ease of Use certification include:

• 
  Ezy Dose Push Button Weekly Pill Organizer (Med)
• Ezy Dose Push Button Weekly Pill Organizer (XL)
• Ezy Dose Push Button Weekly Pill Organizer (2XL)
• Ezy Dose Push Button Weekly AM/PM Pill Organizer
• Ezy Dose Push Button Medtime Planner (2XL)

“Pill organizers make it easier to keep track of which medications you’ve already taken,” said Senior Marketing Manager Jennifer Kallemeyn. “This is especially important when you have multiple medications to take in a day, take different medications on different schedules, or need to take certain medications at specific times. It can be a lot to remember, but a pill planner can help keep things organized.”

The Ease of Use program uses independent testers to ensure products that earn this endorsement make everyday tasks easier for those living with arthritis. Arthritis affects 54 million adults and 300,000 children in the U.S., making it the number one cause of disability in the country. As such, products that earn the Ease of Use label are making everyday tasks easier for a large portion of the population.

“Apothecary Products is proud to be a part of the solution,” Flygare said.

###

About Apothecary Products:

Founded in 1975, Apothecary Products is a global leader in consumer wellness products. Apothecary Products brands help consumers improve their health and wellness and support pharmacists and the patients they serve with innovative pharmacy products. Apothecary Products’ retail brands, Ezy Dose®, Flents®, Protechs® and Wipe ‘N Clear® are market leaders in medication management, pharmacy supply and eye, ear and injury care. Apothecary Products is a worldwide partner with the majority of US retailers (food, drug, mass, club), independent pharmacies and drug wholesalers and has an international presence in over 80 countries. Acquired by Norwest Equity Partners in 2014, Apothecary Products is poised to grow its leadership position by offering the best in branded consumer products and pharmacy supplies to all major classes of trade.

Share article on social media or email:

As the amount of patient data and what organizations want to do with those data increase, the role of clinical data abstractors has moved from data collation and analysis for patient care improvements to tedious data searches and data entry.

TORONTO (PRWEB)
November 11, 2021

Clinical data registries were initiated to improve healthcare processes, and ultimately, patient outcomes, using electronic patient data. However, as the amount of patient data and what organizations want to do with those data increase, the role of clinical data abstractors has moved from data collation and analysis for patient care improvements to tedious data searches and data entry. It is not surprising that these skilled clinical workers are experiencing job dissatisfaction and burnout, leading to high abstractor turnover.

Join our panel discussion with experienced clinical abstractors and hear their personal experiences and how technology-enabled tools and a collaborative environment that prioritizes patient care initiatives, ownership of outcomes and creative approaches to common abstraction roadblocks can turn a tedious job into a rewarding profession.

Join experts from Carta Healthcare, Joh Olson, RN, MBA, Chief Operating Officer, who will moderate the discussion; along with Kelli Campbell, RN, Director of Sales Operations; Betsy Castillo, RN, Abstraction Coordinator (Florida); Dorothy Wong Gottfredson, RN, BSN, Technical Abstractor (California); and Brooke Tepe, RN, BSN, Pediatric Abstractor (Ohio), for the live webinar on Thursday, December 2, 2021 at 2pm EST.

For more information, or to register for this event, visit When Did We Lose Focus on Using Registry Data to Improve Care Delivery, and How Can We Regain It?

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

mHUB MedTech accelerator cohort meets in Chicago for 6-month program

“As a program mentor, I’m excited to welcome to the city a group of hardtech focused healthcare startups that will help revolutionize how we diagnose and manage patients across the world.”

CHICAGO (PRWEB)
November 11, 2021

mHUB, one of the nation’s leading independent hardtech and manufacturing innovation centers, has selected the startup teams that will participate in the premier cohort of its 6-month, hands-on accelerator for high-potential medical device businesses. Teams will move from across the country to participate in the program at mHUB’s state-of-the-art facilities in Chicago. The program is set to commence in November 2021.

Supported by Baxter and Edward-Elmhurst Health Venture Capital, the program’s industry partners will engage with the startups over the course of the program, providing mentorship and guidance for strategic connections within industry and clinical access. Community partner MATTER will provide additional programming and industry access, and Cooley LLP will provide legal programming, resources and office hours.

The selected cohort features early-stage ventures focused on commercializing disruptive medical device solutions such as: a needle-free platform to deliver biologics; wearables for reducing tremors, detecting and treating vestibular disruptions, and capturing wellness markers in elderly patients; as well as monitoring solutions for fetal care, cancer patients, diagnosing sepsis, and tracking IV drug delivery through sensors.

“Chicago is a great place for entrepreneurs, and mHUB has built an incredible community around supporting startups that are manufacturing products, including medical devices,” said Lyle Berkowitz, MD, a Chicagoland physician, entrepreneur, and investor. “As a program mentor, I’m excited to welcome to the city a group of hardtech focused healthcare startups that will help revolutionize how we diagnose and manage patients across the world.”

The selected startups are the result of a rigorous selection process that included an advisory committee of healthcare industry experts, venture capitalists, manufacturers, and serial entrepreneurs. The startups were selected based on their ability to address large, unmet needs with innovative solutions that will transform patient care.

In alphabetical order, cohort teams include:

• 
  Bionode (Indianapolis, Indiana) developing smart contact lens system that rapidly reduces intra-ocular pressure in patients with glaucoma;
• Equibands (Chicago, Illinois): developing Minimize, a lightweight, non-invasive, and discreet bracelet designed to counteract hand tremors – restoring independence for over 120 million people worldwide;
• HIVE (St. Louis, Missouri): developing CloudConnect, a smart IV line that monitors when patients take (and forget to take) IV medication, continuously sending data to clinicians to empower them to act quickly and prevent expensive readmissions;
• Neursantys (Calgary, Alberta, CA): developing NEURVESTA, a wearable which detects neurophysiological impairments disrupting balance and gait and delivers personalized neurostimulation to treat vestibular disruptions caused by aging, head impacts, and other medical conditions;
• NovaXS (Berkeley, CA): developing Telosis, a needle-free medicine delivery platform delivering biologics into the lymphatic system for applications such as gene therapy, oncology, muscular degenerative disease, and endocrinology while improving treatment compliance;
• NXgenPort (St Paul, Minnesota): developing NXgenPort (NGP), a device that maximizes remote care in cancer patients by combining proven chemo-port efficacy with microchip and sensor technology to monitor and report physiological measurements in vivo;
• Ping (Chicago, Illinois): developing wearables that capture the wellness information of seniors to drive up engagement between aging populations and their family caregivers
• ProMedix (Portland, OR): developing HydraSense to provide a rapid, accurate, and noninvasive assessment at the clinical bedside or remote care setting to help diagnose sepsis and monitor patient decline and response to treatment;
• Walela (Mundelein, Illinois): developing sensor technology that measures fetal heart rate and blood pH to improve fetal and maternal outcomes and reduce unnecessary c-sections.

“When the mHUB accelerator program was launched, MedTech was an obvious vertical for mHUB to support,” said Melissa Lederer, mHUB Chief Experience Officer. “The development of medical devices is a complex process. mHUB is positioned to help accelerate the product development of hardware while supporting the teams with the resources, guidance and healthcare industry access they need to navigate the commercialization path to market.”

The MedTech cohort is the second cohort of mHUB’s Accelerated Incubation program launched in 2020. The program was founded to address the specific barriers of bringing a hardtech solution to market. Mainly, the ability to rapidly prototype and scale and connect with investors who realize the upside of disruptive hardware solutions.

The mHUB accelerator provides access to capital through a $15M Product Impact Fund, nearly closed, with follow-on investment opportunities from the program’s corporate partners as well as access to over $6M of capital-intensive prototyping equipment and business resources. It matches seasoned mentors to each startup, focuses on business and leadership training and offers access to a broad manufacturing ecosystem. Being situated in Chicago, one of the nation’s largest manufacturing regions, mHUB has built a supplier network of over 500+ U.S. manufacturers and growing.

“Advances in technology are revolutionizing digital health and personalized medicine,” said Cathy Skinner, CEO, NXgenPort. “The mHUB accelerator program provides tremendous value to a medical device company like NXgenPort that uses microchip and sensor technology to enable remote monitoring of cancer patients. As an entrepreneur with over a decade of startup experience, accessing a prototyping lab as well as investment, on top of mentorship from healthcare leaders in Chicago, is a unique opportunity.”

“The healthcare industry is primed for disruption, partially due to the global COVID-19 pandemic and partially the speed at which smart technologies are transforming industries,” said Heather Walsh, Executive Director, MedTech Cohort, mHUB Accelerator Program. “Demand-driven, novel medical device technologies are being developed in response to the identification of new pain points in healthcare and an understanding of how the current technology can meet those challenges. I’m thrilled to work with this group of startups who are bringing novel approaches to solving large, unmet needs.

The hyper-resourced accelerator program began on November 8 in Chicago.

mHUB will launch additional sector-specific accelerators approximately every six months with the next cohort focused on EnergyTech set to open application early next year. For more information visit http://www.mhubaccelerator.com.

Share article on social media or email:

Raybow PharmaScience attending CPhI Worldwide in Milan

“We are excited to be able to meet our partners and customers in-person” said Halkjaer-Knudsen. “While we have all learned to use zoom, video and other technologies to keep on track, there is no substitute to meeting face-to-face.”

MILAN, Italy (PRWEB)
November 11, 2021

Raybow PharmaScience is attending this three day trade show and conference which wraps up today. This annual event typically attracts thousands of pharma suppliers and buyers across the full supply chain. Raybow last presented in-person at CPhI Worldwide in Frankfurt, Germany in 2019.

This is the one of the first major in-person European shows that Raybow has attended since Covid-19 shut down events and venues across Europe in the spring of 2020. Key executives attending the event include Peter Halkjaer-Knudsen, Executive Vice President, Dr. Dirk Hütten, Senior Director Business Development and Ryan Gil, Senior Manager, Business Development.

Raybow has taken a cautious approach to getting back to travel in an effort to keep employees safe and as a company this is a significant step to a return to more in-person events.

The in-person event runs for 3 days, ending on the 11th. There is also the opportunity for people unable to attend in Italy to set up online meetings following the event. Raybow will attend CPhI China in December in Shanghai and has plans to attend Chemoutsourcing in the U.S. in February, 2022. This will be our first in-person U.S. show since late 2019 although we have attended several virtual shows.

Raybow PharmaScience is a global Contract Drug and Manufacturing Organization (CDMO) with operations in China, Europe and the U.S. Raybow is focused on providing world class research and development capabilities in the pharmaceutical manufacturing space. Raybow has shown its commitment to the R&D side of the business launching two 10,000 square meter R&D centers in the past 3 years alone and hiring more than 600 new chemists in that same time frame. The company will open a 3rd 10,000 square meter R&D center in 2022.

Share article on social media or email:

“RadSite has been very busy over the past year with the launch of version 3.1 of the MIPPA Accreditation Standards (MAP) for advanced diagnostic imaging last fall and the launch of the Cone Beam CT MAP Standards this past spring,” said Carneal.

ANNAPOLIS, Md. (PRWEB)
November 11, 2021

RadSite™, a leading accreditation organization promoting quality-based imaging practices, announced today the final details for its annual accreditation update webinar, which is part of its fall webinar series.

The complimentary webinar, “RadSite Standards and Accreditation Updates—2021 Annual Update and What to Expect in 2022,” will take place on November 17, 2021, 1:00 p.m. to 2:00 p.m. ET. To register for this webinar, click here.

The webinar will feature an overview and updates to RadSite’s MIPPA Accreditation Program Standards and Guide, including the new specialty accreditation modules. RadSite’s leadership will provide helpful insights into the accreditation process. The presentation also will review several new standards and public policy initiatives under development at RadSite. The RadSite webinar will be moderated by Garry Carneal, RadSite’s President & CEO, and will feature RadSite’s senior leadership team:

• 
  Patrick Browning, MD, RadSite Chief Medical Officer
• Mark Casner, FACHE, RadSite Chair, Accreditation Committee
• Julie Irons, RadSite Accreditation Manager
• Phil Patton, PhD, RadSite Chief Physicist Officer
• Eliot Siegel, MD, RadSite Chair, Standards Committee.

“RadSite has been very busy over the past year with the launch of version 3.1 of the MIPPA Accreditation Standards (MAP) for advanced diagnostic imaging last fall and the launch of the Cone Beam CT MAP Standards this past spring,” said Carneal. “This webinar will provide an update of both RadSite’s recent and future standards development activities.”

The first fall webinar addressed “Cone Beam CT Imaging Quality-Based Standards and Payer Requirements”. Click here for the link to Part I and click here for the link to Part II.

RadSite’s next webinar, scheduled for December 8, 2021, is entitled “Promoting the Patient Experience Through the Integration of Leadership Values–A Spotlight on Outpatient Imaging Centers.” The webinar will feature David J. Waldron, CEO of Traction Business Development LLC, and Mark Casner, RadSite Accreditation Committee Chair.

RadSite offers comprehensive, affordable, quality-based accreditation programs that evaluate imaging providers on established industry standards, regulatory requirements, and best practices. Working with health plans and their participating providers also helps raise imaging standards through meaningful imaging quality and patient safety protocols. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services (CMS) and more than 350 payers and radiology benefit managers.

RadSite’s MIPPA Accreditation Program (MAP) covers all advanced diagnostic imaging (ADI) modalities including CT, MRI, and nuclear medicine (such as PET and SPECT) imaging exams. RadSite now offers five (5) accreditation programs:

• Computed Tomography (CT) MAP, version 3.1
• Magnetic Resonance Imaging (MRI) MAP, version 3.1
• Nuclear Medicine (NucMed) MAP, version 3.1 (including SPECT and PET)
• Dental Cone Beam CT MAP, version 1.0
• Medical Cone Beam CT MAP version 1.0.

To learn more about RadSite, visit http://www.radsitequality.com or call us at 410 440-6007. Click here to learn more about RadSite’s upcoming and previous webinars.

About RadSite™ (http://www.RadSiteQuality.com)

Founded in 2005, RadSite’s mission is to promote performance and quality-based practices for imaging systems across the U.S. and its territories. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services (CMS) as an official accreditation organization under the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008. RadSite also is recognized by over 300 payers and has accredited over 1,000 imaging suppliers. RadSite’s programs help assess, track, and report imaging trends to enhance imaging procedures and outcomes. RadSite also offers educational programs, publishes issue briefs, and underwrites research on a complimentary basis to raise awareness of patient safety issues and to promote best practices. The organization is governed by an independent advisory board and committee system, which is open to a wide range of volunteers to ensure transparency and accountability. To learn more about RadSite, please contact us at (443) 440-6007 or info@radsitequality.com.

Share article on social media or email:

Dr. Steve Carstensen and Dr. Lee Surkin

“I couldn’t be more elated with this new development within the organization and enthusiastically look forward to our DSP future and the importance it will continue to hold within our marketplace, continuing to educate doctors on the critical treatment of OSA.” -Lisa Moler, Publisher

SCOTTSDALE, Ariz. (PRWEB)
November 10, 2021

Dental Sleep Practice (DSP), the leading magazine for dentists and dental professionals dedicated to the treatment of sleep breathing disorders, is proud to announce two new editors who are experts in this continually changing and evolving specialty. Steve Carstensen, DDS, will be returning to the DSP team as Chief Dental Editor, and Lee A. Surkin, MD, has been named Chief Medical Editor. Together, these brilliant doctors will be covering the entire gamut of sleep-related breathing disorders in the newly formatted MedMark Media publication.

DSP Publisher Lisa Moler said, “I couldn’t be more elated with this new development within the organization and enthusiastically look forward to our DSP future and the importance it will continue to hold within our marketplace, continuing to educate doctors on the critical treatment of OSA.”

Lee A. Surkin, MD, FACC, FCCP, FASNC, FAASM, is triple board certified in Sleep Medicine, Cardiology, and Nuclear Cardiology. He is President of Empire Sleep Medicine, CardioSleep Diagnostics, and Chief Medical Officer of Sapphire Sleep Ventures and VirtuOx, Inc. Dr. Surkin is founder of the American Academy of Cardiovascular Sleep Medicine, a not-for-profit academic organization dedicated to an interdisciplinary approach to education, supporting clinical and academic research and furthering public awareness of the strong association between cardiovascular disease and sleep disorders. He is also a fellow of the American Academy of Sleep Medicine. Dr. Surkin has co-authored a seminal manuscript titled “Cardiovascular Disorders in Narcolepsy,” published in the prestigious European peer-reviewed journal, Sleep Medicine Reviews in August 2021. With over 24 years of clinical practice as a trailblazer in the fields of cardiovascular disease and sleep medicine, Dr. Surkin focuses on the integrative relationship between cardiovascular disease, sleep disorders, obesity, and stress. In a clinical setting, this is a unique, comprehensive, and effective model for patient care.

Dr. Surkin said, “I am honored to become Dental Sleep Practice’s first Chief Medical Editor and will bring a fresh approach to the collaborative and interdisciplinary relationship that needs to be fostered between dentists and medical doctors. Through shared learning presented in Dental Sleep Practice, we intend to spark communication leading to relationship building and ultimately enhanced patient care.”

Steve Carstensen, DDS, graduated from Baylor College of Dentistry and has practiced in Texas and Washington. He achieved Fellowship in the Academy of General Dentists in recognition of thousands of hours of advanced education in dentistry, with an increasing amount of time in both practice and classwork devoted to sleep medicine. A lifelong educator, Dr. Carstensen is Sleep Education Director for Pankey Institute and lectures on the subject at Spear Education, recognized as among the finest places for dentists to further their education. As a volunteer leader for the American Dental Association, he was a Program Chairman and General Chairman for the Annual Session, the biggest educational event the Association sponsors.

He is the Consultant to the American Dental Association for sleep-related breathing disorders and co-author of a textbook for dentists treating the disease. For the American Academy of Dental Sleep Medicine, he has been a Board Member, Secretary Treasurer, and President-Elect. He also has achieved Certification by the American Board of Dental Sleep Medicine.

Dr. Carstensen said, “Clinicians everywhere are constantly seeking the best new information to be able to help their communities and patients in their office. I’m excited that Dental Sleep Practice has enlarged its vision to embrace collaboration between dentistry and medicine even more broadly. Returning as Chief Dental Editor is a true highlight of my career, and I can’t wait to get to work.”

Sleep Apnea, a sleep disorder that causes breathing to frequently stop and start, has been associated with significant health risks, including high blood pressure, diabetes, obesity, and heart disease. In the national effort to understand, diagnose, and treat this disorder, dental professionals have emerged as an important part of the community seeking to build a knowledge database aimed at alleviating human suffering due to Sleep Apnea.

Dental Sleep Practice has repeatedly been recognized as a leading publication in the dental sleep niche. The journal’s affiliation with The Academy of Clinical Sleep Disorder Disciplines underscores its mission is to provide dentists and clinical teams with online, on-demand access to academically rigorous education and credentialing built upon evidence-based, multidisciplinary scholarship of sleep-related breathing disorders, TMD, and Craniofacial Pain. DSP is specifically designed to serve the professionals whose practices focus on understanding and treating Sleep Apnea disorders in the United States. The publication caters to all in the industry, from newcomers seeking to immerse themselves in best practices to current practitioners sharing their latest insights to service or equipment providers benefiting from a constant and deep connection to current and potential customers.

The new editors are eager to promote the journal’s mission in serving the Dental Sleep community, both from a dental and medical perspective.

MedMark Media has produced dental journals in the fields of endodontics, implants, and orthodontics for 16 years. The company is dedicated to creating a healthier America through knowledge, due diligence, and experience, by empowering dental professionals with high quality clinical information in clear and concise language and showcasing innovative technologies.

For more information please visit: https://dentalsleeppractice.com and https://medmarkmedia.com.

Share article on social media or email:

Mother with her children in front of ShelterBox disaster relief tent following the 2010 Haiti Earthquake.

“We are inspired by the incredible support from across Santa Barbara and the nation from people wanting to help families displaced by disaster and crisis situations,” said Kerri Murray, President of ShelterBox USA.

SANTA BARBARA, Calif. (PRWEB)
November 10, 2021

In what was their most successful virtual fundraising event to date, Santa Barbara-based international disaster relief organization ShelterBox USA raised more than $600,000 at their annual virtual benefit “An Evening to Experience ShelterBox” held November 4, 2021. More than 350 people attended the live-streamed event which was broadcast internationally from the ShelterBox USA headquarters in Santa Barbara, CA.

“We are inspired by the incredible support from across Santa Barbara and the nation from people wanting to help families displaced by disaster and crisis situations,” said Kerri Murray, President of ShelterBox USA. “For many of the guests participating in the live-streamed event, it was their first time learning about the global humanitarian relief efforts of ShelterBox. We are humbled by the generosity and outpouring of charitable support for this lifesaving mission.”

The immersive experience into disaster response work of ShelterBox featured a virtual tour of the ShelterBox family relief tent, which a family up to ten will live in for a period of weeks to months after losing their home in an emergency. In addition to the tent demonstration, the organization highlighted the critical tools and supplies they provide to set up a household in an emergency, including water purification, solar lanterns, cooking equipment and critically needed hygiene supplies to mitigate the spread of COVID-19.

ShelterBox Response Team (SRT) members who have responded to disasters around the world shared deployment stories of the impact ShelterBox aid has on the lives of people who have lost everything after disaster, including in the aftermath of the 7.2 magnitude earthquake that rocked Haiti in August 2021.

The evening’s festivities ramped up when a generous donor spontaneously announced a matching gift of $250,000 if the original goal of $250,000 was reached by the end of the event. In total and with the support of hundreds of individuals, Rotarians, and Foundation support, the night raised more than $600,000 to provide up to 6,000 displaced families with the life-saving emergency shelter and household supplies needed to survive after disaster.

During the event, ShelterBox honored the Dale and Edna Walsh (DEW) Foundation with the 2021 Global Humanitarian Service Award for their extraordinary philanthropic efforts to tackle some of the biggest issues facing the world. This includes the DEW Foundation’s longtime support of ShelterBox and its work in the Syrian refugee crisis. In 2020, DEW Foundation provided hundreds of displaced Syrian families with shelter and basic household items including shelter kits, blankets, and winter clothing to help them survive the cold winter months.

Watch the recording: https://youtu.be/0tyVyBZj-rA

About ShelterBox

ShelterBox provides emergency shelter and life-saving supplies to communities overwhelmed by disaster. Since 2000, ShelterBox has provided shelter, warmth, and dignity following more than 300 disasters across 100 countries, sheltering over 2.2 million people and counting. ShelterBox responds urgently to earthquakes, volcanoes, floods, hurricanes, cyclones, tsunamis, or conflict by delivering boxes of essential shelter, aid, and other critically needed supplies. Each iconic green ShelterBox contains a disaster relief tent for an extended family, blankets, a water filtration system, emergency lighting, and other tools for survival.

ShelterBox was nominated in 2018 and in 2019 for the Nobel Peace Prize for its work in some of the world’s most extreme conflict zones. ShelterBox USA is based in Santa Barbara, California.

To learn how to volunteer, fundraise, or to make a donation to ShelterBox USA, visit http://www.shelterboxusa.org. Legacy giving and corporate giving options are available as well. ShelterBox USA is a 4-Star rated charity by Charity Navigator and has Platinum status from GuideStar.

ShelterBox is the official Project Partner in disaster response of Rotary International. Rotarians are often the first point of contact for the ShelterBox Response Team when they arrive in a country that has been devastated by a disaster. They also help in fundraising and volunteer projects. ShelterBox is a registered charity independent of Rotary International and the Rotary Foundation. Tax-deductible donations to the organization can be made at http://www.ShelterBoxUSA.org or by calling (805) 608 – 2400.

###

Share article on social media or email: